|
LO-1
|
It explains the basic physiological functions of the cardiovascular system and the pathophysiological mechanisms of cardiovascular diseases. |
|
LO-2
|
It describes the etiology, risk factors, clinical findings, and basic diagnostic approaches of common cardiovascular diseases. |
|
LO-3
|
It classifies and describes the drug groups used in the treatment of cardiovascular diseases and their mechanisms of action. |
|
LO-4
|
It evaluates the indications, contraindications, adverse effects, and important drug interactions of cardiovascular system medications. |
|
LO-5
|
Explains the pharmacotherapeutic approaches applied in hypertension, dyslipidemia, coronary artery disease and acute coronary syndromes. |
|
LO-6
|
This section evaluates the role and basic usage principles of medications used in the treatment of heart failure and cardiac arrhythmias. |
|
LO-7
|
This section describes the mechanisms of action, clinical applications, and safety characteristics of anticoagulant, antiplatelet, and thrombolytic drugs. |
|
LO-8
|
In cardiovascular diseases, it evaluates rational and safe drug use by considering patient characteristics, comorbidities, and drug interactions. |